Hence, the high eNOS protein levels in APP mice may reflect a compensatory upregulation in response to the reduced NO bioavailability following its trapping by reactive oxygen species [31,74], as also reported in a model of diabetes-associated vascular disease [78]. This evidence concerns the gene APP and diabetes mellitus.